The company is focused to dispense prescribed medicines at the patient’s doorsteps. “We address chronic patients and serve their planned regular medications. We don’t engage any courier service to offer the
Harnessing the benefits of technology and sourcing, Vpharmacist removes the layers of cost between the manufacturers and the customers
Uplifting the quality in the offerings, the team ensures to maintain the desired temperature using cold box, until the drugs are delivered as the medicines may lose potency. Harnessing the benefits of technology and sourcing Vpharmacist removes the layers of cost between the manufacturers and the customers. Thereby, removes substantial overhead costs of traditional retail pharmacy chains. The team precisely works on how to keep the cost minimal which would be a vast saving for the customers. “Our team has the pride of providing the highest quality of care when customers need it most. While offering transparency and price effectiveness the orders are verified by the experts. With all these attributes, Vpharmacist is recognized as a leading consumer health online platform in Tamilnadu.
Vpharmacist began the journey with an awareness of public service wherein all consumers experience the best service at the best price. Since its inception, it has significantly grown in the market. The company’s financial and other key operational metrics stand distinct & superior in the landscape. “We commenced our operations in Chennai and have expanded our services to three towns in TN with Point of Sale presence. Irrespective of the location, be it city or town or rural area, we dispense the medicines through a team of pharmacists to ensure the desired service levels,” he informs.
The company is looking forward to marking its presence in 15 towns in the next six months. It has also planned to expand operations in 50 towns of Tamilnadu apart from commencing operations in nine more States. “We have recently roped in our first strategic investor, who adds significant value in our business strategy and operations. We have also initiated discussions on the next round of funding,” he concludes.